While my primary expertise is in regulatory affairs within the pharmaceutical industry, I see great potential in integrating more predictive analytics to streamline submissions and monitor post market safety more effectively. While I may not have direct experience in healthcare analytics operations. I appreciate its growing impact on regulatory strategies and patient safety.